Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Expert Opinion on Therapeutic Targets|August 23, 2017
Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?Lucienne Juillerat-Jeanneret, Petra Tafelmeyer, Dela Golshayan
Frontiers in Transplantation|July 12, 2024
Monocyte-derived dendritic cells can be detected in urine of kidney transplant recipients with pathogenic asymptomatic bacteriuriaVanja Salvadé, Oriol Manuel, Dela Golshayan, et al.
Journal of the American Society of Nephrology : JASN|July 13, 2023
Targeting the Complement Pathway in Kidney TransplantationDela Golshayan, Nora Schwotzer, Fadi Fakhouri, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 22, 2006
From current immunosuppressive strategies to clinical tolerance of allograftsDela Golshayan, Leo Buhler, Robert I Lechler, et al.
Frontiers in Medicine|September 13, 2024
Case report: Bruton tyrosine kinase inhibitor as therapy for chronic lymphocytic leukemia infiltrating a kidney allograftLouis Stavart, Matthieu Halfon, Natacha Dewarrat, et al.
Journal of Medicinal Chemistry|July 4, 2018
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ DysfunctionLucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic, et al.
Journal of the American Society of Nephrology : JASN|May 2, 2009
Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRDPascal Meier, Dela Golshayan, Edouard Blanc, et al.
Revue Medicale Suisse|January 16, 2026
[Nephrology : what's new in 2025]Giliane Nanchen, Menno Pruijm, Faïza Lamine, et al.
International Immunopharmacology|December 13, 2006
In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation toleranceShuiping Jiang, Dela Golshayan, Julia Tsang, et al.
Pageof 14